Skip to main content
Erschienen in: Familial Cancer 3/2014

01.09.2014 | Original Article

Influence of family history on psychosocial distress and perceived need for treatment in prostate cancer survivors

Erschienen in: Familial Cancer | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Familial clustering is common in prostate cancer (PCa), but the psychosocial consequences of being a PCa patient in an affected family are not well understood. This study investigated the effects of family history of PCa on psychosocial distress and perceived psychosocial treatment need. Data were gathered within the German national research project “Familial Prostate Cancer”. 4.123 PCa survivors who had undergone prostatectomy at least 4 years ago received a questionnaire set. 3.623 of the respondents [68.3 % sporadic, sporadic prostate cancer (SPCa); 31.7 % familial, familial prosate cancer (FPCa)] filled in measures of cancer-specific distress (QSC-R10), depression (PHQ-2), and anxiety (GAD-2). Perceived psychosocial treatment need was assessed using a single item. The prevalence of psychosocial distress did not differ between SPCa and FPCa survivors (cancer-specific distress: 16.2 vs. 16.7 %; depression: 5.8 vs. 6.4 %; anxiety: 6.6 vs. 5.8 %; ps ≥ .397). Similarly, psychosocial treatment need did not differ between SPCa (11.8 %) and FPCa (13.1 %) cases (p = .303). However, family history moderated the effect of cancer-specific distress on treatment need (OR 2.67, 95 % CI 1.43–4.96, p = .002). Exploratory analyses for the hereditary subtype (HPCa) revealed that cancer-specific distress was lower in HPCa survivors who had only daughters compared to survivors without any children or with at least one son. No such effect was observed in SPCa survivors (p = .040). PCa survivors with a positive family history do not experience increased psychosocial distress. Nonetheless, family history may exert subtle effects that deserve further research.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
2.
Zurück zum Zitat Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J et al (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49:1374–1403PubMedCrossRef Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J et al (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49:1374–1403PubMedCrossRef
3.
Zurück zum Zitat Robert Koch-Institut und Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. (ed): Krebs in Deutschland 2007/2008 [Cancer in Germany 2007/2008]. Berlin, 2012 Robert Koch-Institut und Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. (ed): Krebs in Deutschland 2007/2008 [Cancer in Germany 2007/2008]. Berlin, 2012
4.
Zurück zum Zitat Johns LE, Houlston RS (2003) A systematic review and meta-analysis of familial prostate cancer risk. BJU Int 91:789–794PubMedCrossRef Johns LE, Houlston RS (2003) A systematic review and meta-analysis of familial prostate cancer risk. BJU Int 91:789–794PubMedCrossRef
5.
Zurück zum Zitat Bruner DW, Moore D, Parlanti D et al (2003) Relative risk of prostate cancer for men with affected relatives: systematic review and meta-analysis. Int J Cancer 107:797–803PubMedCrossRef Bruner DW, Moore D, Parlanti D et al (2003) Relative risk of prostate cancer for men with affected relatives: systematic review and meta-analysis. Int J Cancer 107:797–803PubMedCrossRef
6.
Zurück zum Zitat Brandt A, Bermejo JL, Sundquist J et al (2010) Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members. Eur Urol 58:275–280PubMedCrossRef Brandt A, Bermejo JL, Sundquist J et al (2010) Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members. Eur Urol 58:275–280PubMedCrossRef
7.
Zurück zum Zitat Hemminki K (2012) Familial risk and familial survival in prostate cancer. World J Urol 30:143–148PubMedCrossRef Hemminki K (2012) Familial risk and familial survival in prostate cancer. World J Urol 30:143–148PubMedCrossRef
8.
Zurück zum Zitat Hemminki K, Sundquist J, Bermejo JL (2008) How common is familial cancer? Ann Oncol 19:163–167PubMedCrossRef Hemminki K, Sundquist J, Bermejo JL (2008) How common is familial cancer? Ann Oncol 19:163–167PubMedCrossRef
9.
Zurück zum Zitat Herkommer K, Schmidt C, Gschwend JE (2011) Zehn Jahre nationales Forschungsprojekt “Familiäres Prostatakarzinom”. Probleme der Identifikation von Risikofamilien [Ten years national research project “Familial Prostate Cancer”. Problems in identifying risk families]. Urologe 50:813–820PubMedCrossRef Herkommer K, Schmidt C, Gschwend JE (2011) Zehn Jahre nationales Forschungsprojekt “Familiäres Prostatakarzinom”. Probleme der Identifikation von Risikofamilien [Ten years national research project “Familial Prostate Cancer”. Problems in identifying risk families]. Urologe 50:813–820PubMedCrossRef
10.
Zurück zum Zitat Siddiqui SA, Sengupta S, Slezak JM et al (2006) Impact of familial and hereditary prostate cancer on cancer specific survival after radical retropubic prostatectomy. J Urol 176:1118–1121PubMedCrossRef Siddiqui SA, Sengupta S, Slezak JM et al (2006) Impact of familial and hereditary prostate cancer on cancer specific survival after radical retropubic prostatectomy. J Urol 176:1118–1121PubMedCrossRef
11.
Zurück zum Zitat Colloca G, Venturino A (2011) The evolving role of familial history for prostate cancer. Acta Oncol 50:14–24PubMedCrossRef Colloca G, Venturino A (2011) The evolving role of familial history for prostate cancer. Acta Oncol 50:14–24PubMedCrossRef
12.
Zurück zum Zitat Eeles RA, Olama AA, Benlloch S et al (2013) Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet 45:385–391PubMedCrossRef Eeles RA, Olama AA, Benlloch S et al (2013) Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet 45:385–391PubMedCrossRef
14.
Zurück zum Zitat Rubin MA, Maher CA, Chinnaiyan AM (2011) Common gene rearrangements in prostate cancer. J Clin Oncol 29:3659–3668PubMedCrossRef Rubin MA, Maher CA, Chinnaiyan AM (2011) Common gene rearrangements in prostate cancer. J Clin Oncol 29:3659–3668PubMedCrossRef
15.
Zurück zum Zitat Carter B, Bova G, Beaty Y et al (1993) Hereditary prostate cancer: epidemiologic and clinical features. J Urol 150:797–802PubMed Carter B, Bova G, Beaty Y et al (1993) Hereditary prostate cancer: epidemiologic and clinical features. J Urol 150:797–802PubMed
16.
Zurück zum Zitat Kupelian PA, Reddy CA, Reuther AM et al (2006) Aggressiveness of familial prostate cancer. J Clin Oncol 24:3445–3450PubMedCrossRef Kupelian PA, Reddy CA, Reuther AM et al (2006) Aggressiveness of familial prostate cancer. J Clin Oncol 24:3445–3450PubMedCrossRef
17.
Zurück zum Zitat Lee KL, Marotte JB, Ferrari MK et al (2005) Positive family history of prostate cancer not associated with worse outcomes after radical prostatectomy. Urology 65:311–315PubMedCrossRef Lee KL, Marotte JB, Ferrari MK et al (2005) Positive family history of prostate cancer not associated with worse outcomes after radical prostatectomy. Urology 65:311–315PubMedCrossRef
18.
Zurück zum Zitat Roehl KA, Loeb S, Antenor JAV et al (2006) Characteristics of patients with familial versus sporadic prostate cancer. J Urol 176:2438–2442PubMedCrossRef Roehl KA, Loeb S, Antenor JAV et al (2006) Characteristics of patients with familial versus sporadic prostate cancer. J Urol 176:2438–2442PubMedCrossRef
19.
Zurück zum Zitat Rouprêt M, Fromont G, Bitker MO et al (2006) Outcome after radical prostatectomy in young men with or without a family history of prostate cancer. Urology 67:1028–1032PubMedCrossRef Rouprêt M, Fromont G, Bitker MO et al (2006) Outcome after radical prostatectomy in young men with or without a family history of prostate cancer. Urology 67:1028–1032PubMedCrossRef
20.
Zurück zum Zitat Heck MM, Kron M, Gschwend JE et al (2012) Effect of family history on outcome in German patients treated with radical prostatectomy for clinically localised prostate cancer. Eur J Cancer 48:1312–1317PubMedCrossRef Heck MM, Kron M, Gschwend JE et al (2012) Effect of family history on outcome in German patients treated with radical prostatectomy for clinically localised prostate cancer. Eur J Cancer 48:1312–1317PubMedCrossRef
21.
Zurück zum Zitat Jacobson PB, Lamonde LA, Honour M et al (2004) Relation of family history of prostate cancer to perceived vulnerability and screening behaviour. Psychooncology 13:80–85CrossRef Jacobson PB, Lamonde LA, Honour M et al (2004) Relation of family history of prostate cancer to perceived vulnerability and screening behaviour. Psychooncology 13:80–85CrossRef
22.
Zurück zum Zitat McDowell ME, Occhipinti S, Gardiner RA et al (2013) Prevalence and predictors of cancer specific distress in men with a family history of prostate cancer. Psychooncology 22:2496–2504PubMedCrossRef McDowell ME, Occhipinti S, Gardiner RA et al (2013) Prevalence and predictors of cancer specific distress in men with a family history of prostate cancer. Psychooncology 22:2496–2504PubMedCrossRef
23.
Zurück zum Zitat Meiser B, Cowan R, Costello A et al (2007) Prostate cancer screening in men with a family history of prostate cancer: the role of partners in influencing men’s screening uptake. Urology 70:738–742PubMedCrossRef Meiser B, Cowan R, Costello A et al (2007) Prostate cancer screening in men with a family history of prostate cancer: the role of partners in influencing men’s screening uptake. Urology 70:738–742PubMedCrossRef
24.
Zurück zum Zitat Cormier L, Valéri A, Azzouzi R et al (2002) Worry and attitude of men in at-risk families for prostate cancer about genetic susceptibility and genetic testing. Prostate 51:276–285PubMedCrossRef Cormier L, Valéri A, Azzouzi R et al (2002) Worry and attitude of men in at-risk families for prostate cancer about genetic susceptibility and genetic testing. Prostate 51:276–285PubMedCrossRef
25.
Zurück zum Zitat Bratt O, Damber JE, Emanuelsson M et al (2000) Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer. Eur J Cancer 36:235–241PubMedCrossRef Bratt O, Damber JE, Emanuelsson M et al (2000) Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer. Eur J Cancer 36:235–241PubMedCrossRef
26.
Zurück zum Zitat Matthew AG, Paradiso C, Currie KL et al (2011) Examining risk perception among men with a family history of prostate cancer. Patient Educ Couns 85:251–257PubMedCrossRef Matthew AG, Paradiso C, Currie KL et al (2011) Examining risk perception among men with a family history of prostate cancer. Patient Educ Couns 85:251–257PubMedCrossRef
27.
Zurück zum Zitat Tavlarides AM, Ames SC, Diehl NN et al (2013) Evaluation of the association of prostate cancer-specific anxiety with sexual function, depression and cancer aggressiveness in men 1 year following surgical treatment for localized prostate cancer. Psychooncology 22:1328–1335PubMedCrossRef Tavlarides AM, Ames SC, Diehl NN et al (2013) Evaluation of the association of prostate cancer-specific anxiety with sexual function, depression and cancer aggressiveness in men 1 year following surgical treatment for localized prostate cancer. Psychooncology 22:1328–1335PubMedCrossRef
28.
Zurück zum Zitat Paiss T, Herkommer K, Bock B et al (2003) Association between the clinical presentation and epiemiological features of familial prostate cancer in patients selected for radical prostatectomy. Eur Urol 43:615–621PubMedCrossRef Paiss T, Herkommer K, Bock B et al (2003) Association between the clinical presentation and epiemiological features of familial prostate cancer in patients selected for radical prostatectomy. Eur Urol 43:615–621PubMedCrossRef
29.
Zurück zum Zitat Book K, Marten-Mittag B, Henrich G et al (2011) Distress screening in oncology—evaluation of the Questionnaire on Distress in Cancer Patients-Short Form (QSC-R10) in a German sample. Psychooncology 20:287–293PubMedCrossRef Book K, Marten-Mittag B, Henrich G et al (2011) Distress screening in oncology—evaluation of the Questionnaire on Distress in Cancer Patients-Short Form (QSC-R10) in a German sample. Psychooncology 20:287–293PubMedCrossRef
30.
Zurück zum Zitat Herschbach P, Marten-Mittag B, Henrich G (2003) Revision und psychometrische Prüfung des Fragebogens zur Belastung von Krebskranken (FBK-R23) [Revision and psychometric properties of the Questionnaire on Stress in Cancer Patients (QSC-R23)]. Z Med Psychol 12:69–76 Herschbach P, Marten-Mittag B, Henrich G (2003) Revision und psychometrische Prüfung des Fragebogens zur Belastung von Krebskranken (FBK-R23) [Revision and psychometric properties of the Questionnaire on Stress in Cancer Patients (QSC-R23)]. Z Med Psychol 12:69–76
31.
Zurück zum Zitat Herschbach P, Keller M, Knight L et al (2004) Psychological problems of cancer patients: a cancer specific distress screening with a cancer-specific questionnaire. Br J Cancer 91:504–511PubMedPubMedCentralCrossRef Herschbach P, Keller M, Knight L et al (2004) Psychological problems of cancer patients: a cancer specific distress screening with a cancer-specific questionnaire. Br J Cancer 91:504–511PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat Spitzer RL, Kroenke K, Williams JB (1999) Validation and utility of a self-report version of the PRIME-MD: the PHQ primary care study. JAMA 282:1737–1744PubMedCrossRef Spitzer RL, Kroenke K, Williams JB (1999) Validation and utility of a self-report version of the PRIME-MD: the PHQ primary care study. JAMA 282:1737–1744PubMedCrossRef
33.
Zurück zum Zitat Gräfe K, Zipfel S, Herzog W et al (2004) Screening psychischer Störungen mit dem “Gesundheitsfragebogen für Patienten (PHQ-D)”. Ergebnisse der deutschen Validierungsstudie [Screening for psychiatric disorders with the Patient Health Questionnaire: results from the German validation study]. Diagnostica 50:171–181CrossRef Gräfe K, Zipfel S, Herzog W et al (2004) Screening psychischer Störungen mit dem “Gesundheitsfragebogen für Patienten (PHQ-D)”. Ergebnisse der deutschen Validierungsstudie [Screening for psychiatric disorders with the Patient Health Questionnaire: results from the German validation study]. Diagnostica 50:171–181CrossRef
34.
Zurück zum Zitat Löwe B, Wahl I, Rose M et al (2010) A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. J Affect Disord 122:86–95PubMedCrossRef Löwe B, Wahl I, Rose M et al (2010) A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. J Affect Disord 122:86–95PubMedCrossRef
35.
Zurück zum Zitat Dinkel A, Berth H, Tchitchekian G et al (2010) Bedürfnis nach psychosozialer Beratung und Inanspruchnahme psychosozialer Hilfen bei Krebspatienten [Perceived need for psychosocial support and utilization of support services in cancer patients]. In: Berth H (ed) Psychologie und Medizin. Lengerich, Pabst, pp 107–117 Dinkel A, Berth H, Tchitchekian G et al (2010) Bedürfnis nach psychosozialer Beratung und Inanspruchnahme psychosozialer Hilfen bei Krebspatienten [Perceived need for psychosocial support and utilization of support services in cancer patients]. In: Berth H (ed) Psychologie und Medizin. Lengerich, Pabst, pp 107–117
36.
Zurück zum Zitat Geirdal AØ, Dahl AA (2008) The relationship between psychological distress and personality in women from families with familial breast/ovarian or hereditary non-polyposis colorectal cancer in the absence of demonstrated mutations. J Genet Counsel 17:384–393CrossRef Geirdal AØ, Dahl AA (2008) The relationship between psychological distress and personality in women from families with familial breast/ovarian or hereditary non-polyposis colorectal cancer in the absence of demonstrated mutations. J Genet Counsel 17:384–393CrossRef
37.
Zurück zum Zitat Hamilton JG, Lobel M, Moyer A (2009) Emotional distress following genetic testing for hereditary breast and ovarian cancer: a meta-analytic review. Health Psychol 28:510–518PubMedPubMedCentralCrossRef Hamilton JG, Lobel M, Moyer A (2009) Emotional distress following genetic testing for hereditary breast and ovarian cancer: a meta-analytic review. Health Psychol 28:510–518PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Gopie JP, Vasen HFA, Tibben A (2012) Surveillance for hereditary cancer: does the benefit outweigh the psychological burden?—a systematic review. Crit Rev Oncol Hematol 83:329–340PubMedCrossRef Gopie JP, Vasen HFA, Tibben A (2012) Surveillance for hereditary cancer: does the benefit outweigh the psychological burden?—a systematic review. Crit Rev Oncol Hematol 83:329–340PubMedCrossRef
39.
Zurück zum Zitat Rabkin C, Rogers ML, Pinto BM et al (2007) Effect of personal cancer history and family cancer history on levels of psychological distress. Soc Sci Med 64:411–416CrossRef Rabkin C, Rogers ML, Pinto BM et al (2007) Effect of personal cancer history and family cancer history on levels of psychological distress. Soc Sci Med 64:411–416CrossRef
40.
Zurück zum Zitat Kowalkowski MA, Hart SL, Du XL et al (2012) Cancer perceptions: implications from the 2007 Health Information National Trends Survey. J Cancer Surviv 6:287–295PubMedCrossRef Kowalkowski MA, Hart SL, Du XL et al (2012) Cancer perceptions: implications from the 2007 Health Information National Trends Survey. J Cancer Surviv 6:287–295PubMedCrossRef
41.
Zurück zum Zitat Mols F, van de Poll-Franse LV, Vingerhoets JJM et al (2006) Long-term quality of life among Dutch prostate cancer survivors. Results of a population-based study. Cancer 107:2186–2196PubMedCrossRef Mols F, van de Poll-Franse LV, Vingerhoets JJM et al (2006) Long-term quality of life among Dutch prostate cancer survivors. Results of a population-based study. Cancer 107:2186–2196PubMedCrossRef
42.
Zurück zum Zitat Boorjian SA, Eastham JA, Graefen M et al (2012) A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes. Eur Urol 61:664–675PubMedCrossRef Boorjian SA, Eastham JA, Graefen M et al (2012) A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes. Eur Urol 61:664–675PubMedCrossRef
43.
Zurück zum Zitat Kibel AS, Ciezki JP, Klein EA et al (2012) Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era. J Urol 187:1259–1265PubMedCrossRef Kibel AS, Ciezki JP, Klein EA et al (2012) Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era. J Urol 187:1259–1265PubMedCrossRef
44.
Zurück zum Zitat Hruza B, Bermejo JL, Flinspach B et al (2013) Long-term oncological outcomes after laparoscopic radical prostatectomy. BJU Int 111:271–280PubMedCrossRef Hruza B, Bermejo JL, Flinspach B et al (2013) Long-term oncological outcomes after laparoscopic radical prostatectomy. BJU Int 111:271–280PubMedCrossRef
45.
Zurück zum Zitat Walter FM, Emery J (2005) ‘Coming down the line’—patients’ understanding of their family history of common chronic disease. Ann Fam Med 3:405–414PubMedPubMedCentralCrossRef Walter FM, Emery J (2005) ‘Coming down the line’—patients’ understanding of their family history of common chronic disease. Ann Fam Med 3:405–414PubMedPubMedCentralCrossRef
46.
Zurück zum Zitat Spencer BA, Babey SH, Etzioni DA et al (2006) A population-based survey of prostate-specific antigen testing among California men at high risk for prostate carcinoma. Cancer 176:765–774CrossRef Spencer BA, Babey SH, Etzioni DA et al (2006) A population-based survey of prostate-specific antigen testing among California men at high risk for prostate carcinoma. Cancer 176:765–774CrossRef
47.
Zurück zum Zitat Wallner LP, Sarma AV, Lieber MM et al (2008) Psychosocial factors associated with an increased frequency of prostate cancer screening in men ages 40 to 79 years: the Olmsted County Study. Cancer Epidemiol Biomarkers Prev 17:3588–3592PubMedPubMedCentralCrossRef Wallner LP, Sarma AV, Lieber MM et al (2008) Psychosocial factors associated with an increased frequency of prostate cancer screening in men ages 40 to 79 years: the Olmsted County Study. Cancer Epidemiol Biomarkers Prev 17:3588–3592PubMedPubMedCentralCrossRef
48.
Zurück zum Zitat Patenaude AF, DeMarco TA, Peshkin BN et al (2013) Talking to children about maternal BRCA1/2 genetic test results: a qualitative study of parental perceptions and advice. J Genet Counsel 22:303–314CrossRef Patenaude AF, DeMarco TA, Peshkin BN et al (2013) Talking to children about maternal BRCA1/2 genetic test results: a qualitative study of parental perceptions and advice. J Genet Counsel 22:303–314CrossRef
49.
Zurück zum Zitat Esplen MJ, Madlensky L, Aronson M et al (2007) Colorectal cancer survivors undergoing genetic testing for hereditary non-polyposis colorectal cancer: motivational factors and psychosocial functioning. Clin Genet 72:394–401PubMedCrossRef Esplen MJ, Madlensky L, Aronson M et al (2007) Colorectal cancer survivors undergoing genetic testing for hereditary non-polyposis colorectal cancer: motivational factors and psychosocial functioning. Clin Genet 72:394–401PubMedCrossRef
50.
Zurück zum Zitat Atkinson TM, Noce NS, Hay J et al (2013) Ilness-related distress in women with clinically localized cutaneous melanoma. Ann Surg Oncol 20:675–679PubMedPubMedCentralCrossRef Atkinson TM, Noce NS, Hay J et al (2013) Ilness-related distress in women with clinically localized cutaneous melanoma. Ann Surg Oncol 20:675–679PubMedPubMedCentralCrossRef
51.
Zurück zum Zitat Stinesen-Kollberg K, Thorsteinsdottir T, Wilderäng U et al (2013) Worry about one’s own children, psychological well-being, and interest in psychosocial intervention. Psychooncology 22:2117–2123PubMedCrossRef Stinesen-Kollberg K, Thorsteinsdottir T, Wilderäng U et al (2013) Worry about one’s own children, psychological well-being, and interest in psychosocial intervention. Psychooncology 22:2117–2123PubMedCrossRef
52.
Zurück zum Zitat Eisinger F, Bouhnik AD, Malavolti L et al (2011) Cancer survivors: familial risk perception and management advice given to their relatives. Fam Cancer 10:147–155PubMedCrossRef Eisinger F, Bouhnik AD, Malavolti L et al (2011) Cancer survivors: familial risk perception and management advice given to their relatives. Fam Cancer 10:147–155PubMedCrossRef
Metadaten
Titel
Influence of family history on psychosocial distress and perceived need for treatment in prostate cancer survivors
Publikationsdatum
01.09.2014
Erschienen in
Familial Cancer / Ausgabe 3/2014
Print ISSN: 1389-9600
Elektronische ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-014-9715-6

Weitere Artikel der Ausgabe 3/2014

Familial Cancer 3/2014 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.